GlassScriptPhysician profile
Richard J Egerman
NPI 1699796961
$1,963.72
in general payments reported to CMS, 2019-2025
27 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.12 · 2020: $191 · 2021: $41.71 · 2022: $159 · 2023: $277 · 2024: $686 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,481.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $313.57 | 2023-2024 | Eterna, Esprit, Proclaim |
| Cardiovascular Systems INC. | $146.95 | 2020-2022 | |
| Djo, LLC | $144.67 | 2019-2025 | Cmf |
| Organogenesis INC. | $144.56 | 2023-2025 | Via Matrix, Apligraf, Puraply |
| Penumbra, INC. | $144.30 | 2025 | Indigo System |
| Medtronic, INC. | $134.13 | 2024 | Endurant Iis |
| Boston Scientific Corporation | $127.74 | 2025 | Accolade Sr |
| Angiodynamics, INC. | $123.23 | 2023 | Auryon Laser System 100-120 Vac |
| Paratek Pharmaceuticals, INC. | $106.92 | 2022-2025 | Nuzyra |
| Smith+Nephew, INC. | $98.85 | 2022-2024 | Grafix, Stravix, Grafix Pl |
| Stability Biologics, LLC | $73.97 | 2022 | |
| Amgen INC. | $41.63 | 2024 | Krystexxa |
| Melinta Therapeutics, LLC | $40.15 | 2019 | |
| Treace Medical Concepts, INC. | $36.67 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $30.63 | 2025 | Purified Cortrophin Gel |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $30.29 | 2024 | Motoband |
| Nabriva Therapeutics, Plc | $28.32 | 2020-2021 | |
| Kerecis Limited | $25.92 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $25.57 | 2024 | Restrata Wound Matrix |
| Nevro Corp. | $24.90 | 2023 | Senza |
| Biotissue Holdings INC. | $24.49 | 2024 | |
| Wright Medical Technology, INC. | $22.02 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $17.41 | 2025 | Exparel |
| Cook Medical LLC | $15.58 | 2025 | Zilver Ptx |
| Merck Sharp & Dohme LLC | $14.67 | 2019 | |
| Horizon Therapeutics Plc | $13.42 | 2021 | |
| Zyla Life Sciences, INC. | $13.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Egerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.